| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Angiodynamics Inc (ANGO) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. ANGO is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 882.5K | $10.72M | - | |
| CFO | 256.6K | $3.12M | - | |
| Dir | 167.1K | $2.03M | - | |
| Dir | 143.5K | $1.74M | - | |
| Dir | 105.0K | $1.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2022 | Clemmer James C50 | President And CEO | Buy | 10,000 | $15.00 | $150,000.00 | +2.3% | +1.3% | -48.6% | |
| Jul 29, 2022 | Helsel Dave71 | SVP Global Operations And R&D | Sell | 5,000 | $22.44 | $112,200.00 | -17.3% | -41.3% | -61.9% | |
| Apr 28, 2022 | Helsel Dave71 | SVP Global Operations And R&D | Sell | 3,513 | $22.44 | $78,831.72 | -13.3% | +0.6% | -63.0% | |
| Apr 12, 2022 | Johnson Wesley | - | Sell | 7,500 | $23.05 | $172,837.74 | -4.5% | -13.2% | -60.1% | |
| Jan 12, 2022 | Trowbridge Stephen A | EVP And CFO | Buy | 1,000 | $22.64 | $22,640.00 | +1.3% | +4.6% | -37.7% | |
| Jan 11, 2022 | Clemmer James C50 | President And CEO | Buy | 10,000 | $22.84 | $228,400.00 | +2.6% | -4.0% | -43.2% | |
| Oct 20, 2021 | Helsel Dave71 | SVP Global Operations And R&D | Sell | 3,494 | $27.97 | $97,727.18 | -11.7% | -20.6% | -52.2% | |
| Oct 15, 2021 | Centea Scott | Sr. Vp/ Gm, Global Vit | Sale+OE | 12,000 | $27.92 | $335,040.00 | -20.6% | -17.9% | -47.5% | |
| Oct 5, 2021 | Campbell Chad Thomas | Svp/ Gm, Vascular Access | Sale+OE | 10,748 | $27.15 | $291,808.20 | -25.3% | +6.0% | -21.7% | |
| Apr 14, 2021 | Helsel Dave71 | SVP Global Operations And R&D | Sell | 3,500 | $23.93 | $83,755.00 | -15.5% | +15.0% | -4.0% |